Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Employees

Alnylam Pharmaceuticals had 2,500 employees as of December 31, 2025. The number of employees increased by 270 or 12.11% compared to the previous year.

• Employees: 2,500
• Change (1Y): 270
• Growth (1Y): 12.11%
• Revenue / Employee: $1,714,769
• Profits / Employee: $215,196
• Market Cap: 38.90B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	2,500	270	12.11%
Dec 31, 2024	2,230	130	6.19%
Dec 31, 2023	2,100	98	4.90%
Dec 31, 2022	2,002	337	20.24%
Dec 31, 2021	1,665	212	14.59%
Dec 31, 2020	1,453	130	9.83%
Dec 31, 2019	1,323	258	24.23%
Dec 31, 2018	1,065	316	42.19%
Dec 31, 2017	749	235	45.72%
Dec 31, 2016	514	145	39.30%
Dec 31, 2015	369	113	44.14%
Dec 31, 2014	256	91	55.15%
Dec 31, 2013	165	36	27.91%
Dec 31, 2012	129	13	11.21%
Dec 31, 2011	116	-56	-32.56%
Dec 31, 2010	172	-6	-3.37%
Dec 31, 2009	178	8	4.71%
Dec 31, 2008	170	41	31.78%
Dec 31, 2007	129	7	5.74%
Dec 31, 2006	122	28	29.79%
Dec 31, 2005	94	23	32.39%
Dec 31, 2004	71	11	18.33%
Dec 31, 2003	60	-	-

Data Source: Official company filings Last updated: Dec 31, 2025

The employees data for this stock was gathered manually by the Stock Analysis team based on SEC filings and investor relations materials.

Update frequency:

Yearly

Last checked:

Jun 27, 2026

Data Sources Report a data error